Capital Bancorp vs NewtekOne
CBNK and NEWT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBNK and NEWT compare
Capital Bancorp is the larger company, worth 2.3 times as much as NewtekOne ($672M against $296M).
On earnings, NewtekOne is cheaper: it trades at 4.7× trailing earnings, against 12.1× for Capital Bancorp.
Capital Bancorp grew revenue faster over the last twelve months (15.1% versus 7.1% for NewtekOne).
NewtekOne keeps more of each dollar of sales as profit, with a net margin of 22.2% compared with 22.2% at Capital Bancorp.
Both pay dividends: Capital Bancorp yields 1.3% and NewtekOne 7.4%.
NewtekOne scores higher on the StockData Score (20 against 15 for Capital Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBNK | NEWT |
|---|---|---|
| Size and price | ||
| Market cap | $672M | $296M |
| Share price | $41.26 | $10.25 |
| Change, 1 year | 48.5% | 2.0% |
| Change, 5 years | 55.7% | −65.6% |
| Beta (5Y) | 0.18 | 1.18 |
| Employees | 459 | 109 |
| StockData Score | ||
| Total score | 15 | 20 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 4 (better) | 3 |
| Health score | 4 | 5 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 12.1× | 4.7× (better) |
| P/S | 2.6× | 1.0× (better) |
| P/B | 1.6× | 0.7× (better) |
| PEG | 2.24 | 0.26 (better) |
| FCF yield | – | −250% |
| Fair value | $34.99 | $18.98 |
| Margin of safety | −17.9% | 46.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.1% (better) | 7.1% |
| Revenue growth, 5Y average | 12.8% | – |
| Net income growth (TTM) | 30.3% (better) | 22.7% |
| EPS growth (TTM) | 27.3% (better) | 9.5% |
| EPS growth, 5Y average | 12.8% | – |
| Profitability | ||
| Net margin | 22.2% | 22.2% (better) |
| FCF margin | – | −251% |
| Return on equity | 14.1% | 18.0% (better) |
| Financial health | ||
| Altman Z-score | 0.29 (better) | 0.20 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | 7.4% (better) |
| Payout ratio | 14.0% | 46.6% |
| Years of dividend growth | 4 (better) | 0 |
| Buyback yield | 1.8% | – |
| Shareholder yield | 3.0% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 45.4% | 55.7% |
| Held by insiders | 25.6% | 17.2% |
| Insider net buying, 12 months | $0 | $434K (better) |
| Short interest, % of float | 4.5% | – |
Go deeper
- CBNK stock overview
- CBNK income statement
- CBNK valuation and score
- NEWT stock overview
- NEWT income statement
- NEWT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.